Phytex exceeds expectations in removal of Pyrrolizidine Alkaloids
Phytex was recently approached by a customer with a request to remove Pyrrolizidine Alkaloids (PAs) impurities from its raw herbal...
top of page
Our mission
Our mission is to develop, scale and commercialise high quality active pharmaceutical ingredients (APIs) for the global healthcare and research industry.
We strive to pursue long-term partnership opportunities with industry leaders built on collaboration, innovation, quality and regulatory support while delivering the highest quality products.
Our products
Scopolamine Hydrobromide
USP
Scopolamine Hydrobromide is used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics.
Scopolamine Base
EP
As with Scopolamine Hydrobromide, Scopolamine Base is used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics.
Hyoscine Hydrobromide
EP
As with Scopolamine Hydrobromide, Hyoscine Hydrobromide is also used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics.
Atropine Base
USP & EP
Atropine is a muscarinic antagonist used to treat poisoning by muscarinic agents, including organophosphates and other drugs. An alkaloid, originally from Atropa belladonna, but found in other plants (Duboisia, Datura), mainly solanaceae.
Methscopolamine Bromide
USP
Methscopolamine is used to treat a particular stomach/intestinal ulcer (peptic ulcer). It works by decreasing the amount of acid in the stomach, slowing the natural movements of the gut and relaxing the muscles in the stomach/intestines. Methscopolamine belongs to a class of drugs known as anticholinergics
Our commitment to quality and compliance
Phytex maintains the highest quality standards, manufacturing in strict accordance with GMP and ICH Quality Guidelines – PIC/s - ICH Q7 - as well as 21 CFR part 210 and 211.
Phytex holds current regulatory licensing with the Australian Therapeutic Goods Administration (TGA) and is routinely inspected by the U.S. Food and Drug Administration (DMF 7406), as part of product development, research and development, New Drug Applications and Abbreviated New Drug Applications with global pharmaceutical companies.
Phytex adopts the Pharmaceutical Inspection Cooperation Scheme Good Manufacturing Practice (PIC/S GMP) standards at every stage, beginning with the harvest of raw botanical materials, through to quality assurance of procedures and quality control of upscaled commercial manufacturing practices.
bottom of page